Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Floods hit Ukraine after Kakhovka dam breached
    • Military briefing: Russia has most to gain from Ukrainian dam breach
    • Chris Christie takes on Donald Trump with second US presidential run
    • France objects to Nato plan for office in Tokyo
    • Serbia backs ammunition shipments to Ukraine in westward pivot
  • UK
    Sections
    • UK Home
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
    Most Read
    • Prince Harry says UK government at ‘rock bottom’
    • UK grocery spending soars as food prices rise
    • Rishi Sunak seeks to burnish UK’s global credentials on Washington trip
    • UK banks fear rush to remortgage as lenders raise rates further
    • CBI wins vote of confidence after claims of misconduct
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Saudi Arabia to spend billions on shock merger of PGA Tour and LIV Golf
    • Apple unveils Vision Pro ‘mixed reality’ headset
    • Half of big multinationals plan to cut office space in next three years
    • Deal drought raises stakes for boutiques
    • Labour donor to challenge UK tax authority over private equity payouts
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Live news updates from June 6: SEC sues Coinbase, PGA Tour and Saudi-backed LIV Golf agree to merge
    • ‘Fear of missing out’ drives retail investors to ride AI wave
    • SEC sues Coinbase in widening crackdown on crypto exchanges
    • Crypto exchange Binance sued by SEC in latest blow from US regulators
    • Opec+ is not on board with Saudi Arabia’s ‘whatever it takes’ message
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Dam breach gives Russia a new weapon in Ukraine war
    • Don’t blame the west if the global south goes its own way
    • How the digital nomad went corporate
    • How America is reshaping the global economy
    • Will the 22ers become a new political generation?
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Anti-monarchist Graham Smith: The British royals are ‘tax-funded Kardashians’
    • Can a virtual PA turbocharge your career?
    • FT business books: what to read this month
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • My search for the ‘perfect’ all-round swimsuit
    • Men, where to find the perfect T-shirt
    • Ask Adeela: what’s the best sunscreen?
    • Sci-fi writer Ted Chiang: ‘The machines we have now are not conscious’
    • The Everything Blueprint — how British chip company Arm became a global powerhouse
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

CVS Health Corp

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Wednesday, 8 February, 2023
    Lex
    CVS/Oak Street: acquisition will take time to pay off Premium content

    Pharmacy chain hopes deal for primary care centre operator will speed up push into other parts of US healthcare

  • Wednesday, 2 November, 2022
    US opioid epidemic
    US pharmacy groups CVS and Walgreens agree $10bn opioid settlements

    Other chains also in talks over claims linked to their roles in crisis

  • Tuesday, 6 September, 2022
    LexMergers & Acquisitions
    CVS/Signify: victory in Amazon shootout comes at a cost Premium content

    Move fits with drugstore operator’s effort to shift from retail roots — but it is paying a hefty premium

  • Monday, 5 September, 2022
    CVS buys home healthcare group Signify Health for $8bn

    Amazon was among bidders for Texas-based company as operators in sector seek to diversify

  • Friday, 17 December, 2021
    News in-depthCovid-19 vaccines
    Americans rush for vaccine boosters ahead of Omicron wave

    Pharmacy chains struggle with record demand as waiting times for jabs stretch to two weeks

  • Monday, 15 February, 2021
    Tom Peters
    McKinsey’s work on opioid sales represents a new low

    My former consultancy demonstrates what is wrong with business school graduates

  • Tuesday, 17 November, 2020
    Amazon.com
    Amazon launches online pharmacy in challenge to traditional retailers

    Shares in Walgreens and CVS hit as ecommerce giant offers huge discounts on prescription drugs

  • Wednesday, 6 November, 2019
    CVS quarterly results lifted by higher prices for brand name drugs

    US drugstore chain raises earnings outlook sending shares higher

  • Tuesday, 11 June, 2019
    Digital health
    Digital health breakthrough as US insurers agree to pay for insomnia app

    Deal with CVS Health means digital treatment can be paid for in same way as sleeping pills

  • Tuesday, 9 April, 2019
    Drug prices
    Pharmacy benefit managers face bipartisan criticism

    Republican and Democratic senators accuse industry intermediaries of harming consumers

  • Wednesday, 20 February, 2019
    CVS shares eye biggest drop since October on weak 2019 outlook
  • Tuesday, 29 January, 2019
    Apple Inc
    Apple and Aetna team up on new healthcare app

    Latest push by Silicon Valley tech company into healthcare sector

  • Tuesday, 15 January, 2019
    Walmart to split from CVS pharmacy network

    Companies disagreed over reimbursements for filling prescriptions

  • Tuesday, 6 November, 2018
    CVS Health says Aetna acquisition to close before Thanksgiving
  • Wednesday, 10 October, 2018
    Insurance
    US authorities clear CVS’s $69bn takeover of Aetna

    Approval for huge healthcare combination after agreement to sell prescriptions business

  • Monday, 17 September, 2018
    US & Canadian companies
    DoJ clears Cigna’s $67bn acquisition of Express Scripts
  • Wednesday, 8 August, 2018
    Retail & Consumer industry
    Stronger prescription drug sales boost CVS revenues
  • Thursday, 12 July, 2018
    Insurance
    CVS, Aetna shares lifted by report that DoJ may clear $69bn deal
  • Friday, 29 June, 2018
    The FT ViewFinancial & markets regulation
    Amazon’s unparalleled power over markets

    When the US internet retailer sneezes, entire industries catch cold

  • Friday, 29 June, 2018
    News in-depthUS & Canadian companies
    Amazon kick-starts campaign to disrupt pharmacy sector

    PillPack deal offers the US group a launch pad for a hallmark full-frontal assault

  • Monday, 28 May, 2018
    News in-depthUS & Canadian companies
    Organic tampons escalate battle in feminine care

    Retailers clear way for upstarts as mainstream brands come under scrutiny

  • Sunday, 6 May, 2018
    US & Canadian companies
    Pharma and healthcare companies braced for Trump shake-up

    US president expected to outline plans in speech to lower drug prices

  • Monday, 16 April, 2018
    Retail & Consumer industry
    Drug sellers get a shot in the arm from Amazon report
  • Thursday, 22 March, 2018
    News in-depthUS & Canadian companies
    Death of Texas teacher highlights true cost of US drugs

    Flu victim should have paid much less for her medication, data show

  • Thursday, 8 March, 2018
    News in-depthUS & Canadian companies
    Cigna grabs vital scale with $67bn deal for Express Scripts

    Takeover of pharmacy benefits manager to provide clout when buying drugs and services

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • UK
    • UK Business & Economy
    • UK Politics & Policy
    • Brexit
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In